Covered recipient · General Payments record
GEITH H SHAHOUD
Allopathic & Osteopathic Physicians Psychiatry & Neurology Psychiatry
General Payments · PY2019–2024
$3,447.27
- Reported across 264 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $727.23 | 54 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $405.41 | 39 |
| Alkermes, Inc. | $75.35 | 3 |
| Otsuka America Pharmaceutical, Inc. | $61.82 | 3 |
| Teva Pharmaceuticals USA, Inc. | $46.14 | 2 |
| Neurocrine BioSciences, Inc. | $33.54 | 2 |
| Vanda Pharmaceuticals Inc. | $23.30 | 1 |
| Janssen Pharmaceuticals, Inc | $22.39 | 1 |
| Supernus Pharmaceuticals, Inc. | $22.37 | 1 |
| Lundbeck LLC | $19.13 | 1 |
| Corium, Inc. | $17.78 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (54)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $7.54 | 01/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106069324 | CMS |
| ABBVIE INC. | $6.88 | 01/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106069326 | CMS |
| ABBVIE INC. | $4.00 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106069328 | CMS |
| ABBVIE INC. | $4.75 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106069330 | CMS |
| ABBVIE INC. | $5.58 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106069332 | CMS |
| ABBVIE INC. | $18.16 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106069334 | CMS |
| ABBVIE INC. | $5.73 | 01/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106069336 | CMS |
| ABBVIE INC. | $24.54 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106069338 | CMS |
| ABBVIE INC. | $9.47 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106069340 | CMS |
| ABBVIE INC. | $9.19 | 02/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106069342 | CMS |
| ABBVIE INC. | $23.85 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106069344 | CMS |
| ABBVIE INC. | $16.56 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106069346 | CMS |
| ABBVIE INC. | $9.75 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106069348 | CMS |
| ABBVIE INC. | $11.26 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106069350 | CMS |
| ABBVIE INC. | $19.46 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106069352 | CMS |
| ABBVIE INC. | $14.87 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106069354 | CMS |
| ABBVIE INC. | $13.68 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106069356 | CMS |
| ABBVIE INC. | $6.43 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106069358 | CMS |
| ABBVIE INC. | $10.56 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106069360 | CMS |
| ABBVIE INC. | $15.58 | 06/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106069362 | CMS |
| ABBVIE INC. | $21.08 | 06/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106069364 | CMS |
| ABBVIE INC. | $8.82 | 07/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106069366 | CMS |
| ABBVIE INC. | $5.79 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106069368 | CMS |
| ABBVIE INC. | $2.55 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106069370 | CMS |
| ABBVIE INC. | $19.33 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106069372 | CMS |
| ABBVIE INC. | $11.23 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106069374 | CMS |
| ABBVIE INC. | $6.69 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106069376 | CMS |
| ABBVIE INC. | $6.49 | 10/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106069378 | CMS |
| ABBVIE INC. | $5.08 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106069380 | CMS |
| ABBVIE INC. | $5.21 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106069382 | CMS |
| ABBVIE INC. | $5.65 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106069384 | CMS |
| ABBVIE INC. | $5.07 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106069386 | CMS |
| ABBVIE INC. | $4.53 | 11/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106069388 | CMS |
| ABBVIE INC. | $7.16 | 11/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106069390 | CMS |
| ABBVIE INC. | $6.80 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106069392 | CMS |
| ABBVIE INC. | $21.17 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106069394 | CMS |
| ABBVIE INC. | $6.33 | 12/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106069396 | CMS |
| ABBVIE INC. | $9.81 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106069398 | CMS |
| ABBVIE INC. | $8.78 | 12/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106069400 | CMS |
| Alkermes, Inc. | $23.98 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120595812 | CMS |
| Alkermes, Inc. | $16.55 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120595814 | CMS |
| Alkermes, Inc. | $34.82 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120595816 | CMS |
| Corium, LLC | $17.78 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100171396 | CMS |
| Janssen Pharmaceuticals, Inc | $22.39 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078149891 | CMS |
| Lundbeck LLC | $19.13 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145967946 | CMS |
| Neurocrine Biosciences, Inc. | $14.28 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150876978 | CMS |
| Neurocrine Biosciences, Inc. | $19.26 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150861415 | CMS |
| Otsuka America Pharmaceutical, Inc. | $17.13 | 01/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118980030 | CMS |
| Otsuka America Pharmaceutical, Inc. | $23.17 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118980032 | CMS |
| Otsuka America Pharmaceutical, Inc. | $21.52 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118980034 | CMS |
| Supernus Pharmaceuticals, Inc. | $22.37 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147828767 | CMS |
| Teva Pharmaceuticals USA, Inc. | $24.16 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151716472 | CMS |
| Teva Pharmaceuticals USA, Inc. | $21.98 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151716612 | CMS |
| Vanda Pharmaceuticals Inc. | $23.30 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133919793 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.